机构:
Univ Penn, Sch Med, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USAUniv Penn, Sch Med, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA
Stotland, BR
[1
]
Cirigliano, MD
论文数: 0引用数: 0
h-index: 0
机构:
Univ Penn, Sch Med, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USAUniv Penn, Sch Med, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA
Cirigliano, MD
[1
]
Lichtenstein, GR
论文数: 0引用数: 0
h-index: 0
机构:
Univ Penn, Sch Med, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USAUniv Penn, Sch Med, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA
Lichtenstein, GR
[1
]
机构:
[1] Univ Penn, Sch Med, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA
Inflammatory bowel disease is a spectrum of disorders whose etiology and pathogenesis are unclear. No therapy is standard; many modalities exist for management. New drugs, improved formulations of existing drugs, combination therapy, and biologic agents offer more effective relief and maintain disease remission.
机构:
Univ Penn, Div Gastroenterol, Dept Med, Sch Med, Philadelphia, PA 19104 USAUniv Penn, Div Gastroenterol, Dept Med, Sch Med, Philadelphia, PA 19104 USA
机构:
Department of Gastroenterology,CHU Sart-Tilman,University of Liège,4000 Liège,BelgiumDepartment of Gastroenterology,CHU Sart-Tilman,University of Liège,4000 Liège,Belgium